James M. Inhofe bought Celgene Corporation (CELG)
James M. Inhofe (R-OK), a U.S. Senator, has disclosed 4 trades in Celgene Corporation (CELG) since 2018, 2 purchases and 2 sales, worth an estimated $173K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James M. Inhofe bought $50,001 - $100,000 of Celgene Corporation (CELG) on February 22, 2018. Since that trade, CELG is up +0.00% against the S&P 500 up +211.65%, an outperformance of -211.65%.
Across these filings, James M. Inhofe has been a balanced trader of CELG (a buy-to-sell ratio of 1.00). The most recent disclosed CELG transaction shown was dated December 31, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James M. Inhofe's CELG trades vs the price
CELG is up +0.00% since James M. Inhofe bought on February 22, 2018, versus +211.65% for the S&P 500.
Performance since this trade
All James M. Inhofe CELG trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| December 31, 2018 | SELL | $15,001 - $50,000 | N/A | — | |
| November 16, 2018 | SELL | $15,001 - $50,000 | N/A | — | |
| July 12, 2018 | BUY | $15,001 - $50,000 | N/A | — | |
| February 22, 2018 | BUY | $50,001 - $100,000 | N/A | — |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James M. Inhofe & CELG trading FAQ
Is it legal for James M. Inhofe to trade Celgene Corporation (CELG) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Celgene Corporation (CELG), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James M. Inhofe buy CELG?
James M. Inhofe disclosed a purchase of $50,001 - $100,000 of Celgene Corporation (CELG) on February 22, 2018, according to public STOCK Act filings.
How has CELG performed since James M. Inhofe's trade?
Since James M. Inhofe bought CELG on February 22, 2018, the stock is up +0.00%, versus +211.65% for the S&P 500 over the same period, an outperformance of -211.65%.
How many times has James M. Inhofe traded CELG?
James M. Inhofe has disclosed 4 CELG trades since 2018 (2 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CELG trades?
Quantellect tracks every disclosed congressional trade in Celgene Corporation (CELG) on the Celgene Corporation congressional trading page, which aggregates filings across all members of Congress.
James M. Inhofe's CELG tradesAll congressional filings for Celgene CorporationJames M. Inhofe's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.